Stratec SE (LTS:0RAR)
€ 31.9 0.4 (1.27%) Market Cap: 390.21 Mil Enterprise Value: 497.36 Mil PE Ratio: 38.92 PB Ratio: 1.72 GF Score: 83/100

Stratec SE at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 07:15PM GMT
Release Date Price: €86.32 (+3.11%)
Federica Lussana

Good morning, everyone. My name is Federica Lussana, and I'm part of the healthcare investment banking team at JPMorgan. It is my pleasure to introduce our next presenting company, STRATEC. You're going to hear from Marcus Wolfinger, CEO of the company. (Operator Instructions) And with that said, let me hand it over to Marcus, and thanks all for joining us today.

Marcus Wolfinger
Stratec SE - Chairman of Board of Management & CEO

Yes. Thanks, Federica, and good morning, everybody. Welcome to the presentation of STRATEC. We'll be providing forward-looking information. I was intending to split this presentation into 4 major segments. Like please allow me for 3 minutes for those ones of you who are new to the story to like either get you up to speed or get you an intro into the story. Then I would like to discuss our strategy and what we are planning to do, followed by some figures. And at the end, obviously, the chance to discuss certain elements of the presentation. We develop and manufacture analyzer systems, plastic consumables and in some cases

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot